MRS in the failing heart: From mice to humans

Research output: Contribution to journalArticle

Abstract

Heart failure (HF) affects over 5 million Americans and takes a significant toll of morbidity, mortality, and health-care costs worldwide. The hypothesis that abnormalities in myocardial energy production are present and underlie human HF is logical and compelling. Adenosine triphosphate (ATP) is the biochemical energy that fuels muscular contraction, and creatine kinase (CK) reaction is the primary energy reserve. Phosphorus (31P) magnetic resonance spectroscopy (MRS) is uniquely capable of measuring the principle substrates in the CK reaction in the living heart noninvasively. Experimental studies in animal models show that reductions in myocardial CK energy reserve significantly limit contractile reserve in normal hearts. Moreover, substrate reductions of [ATP], phosphocreatine (PCR), and PCR/ATP ratios observed by 31P MRS in failing hearts coincide with impaired systolic and diastolic function. The consistency of these findings across multiple species and etiologies argues strongly that metabolic abnormalities in CK energy reserve are a critical component of HF, possibly contributing to its pathophysiology. The recent extension of 31P MRS to noninvasive measurements of ATP flux through CK shows flux reductions in mild-to-moderate human HF that exceed those in the underlying substrates, and reduced CK flux is an independent predictor of subsequent clinical HF events including hospitalizations and death. Mouse models in which expression of CK is knocked out, augmented, or switched on and off are available. In two different murine models of cardiomyopathy, these methods showed that CK overexpression improves contractile function and survival. These findings suggest that impaired cardiac energetics play a central role in HF, that 31P MRS measurements could complement existing risk assessment metrics for HF patients, that strategies to augment CK ATP metabolism in the failing human heart should be pursued and that 31P MRS offers a powerful and unique tool to evaluate both the underlying causes of HF and new treatment strategies.

Original languageEnglish (US)
Pages (from-to)1271-1282
Number of pages12
JournaleMagRes
Volume5
Issue number2
DOIs
StatePublished - 2016

Fingerprint

Magnetic resonance spectroscopy
Creatine Kinase
Magnetic Resonance Spectroscopy
Heart Failure
Adenosine Triphosphate
Phosphocreatine
Fluxes
MB Form Creatine Kinase
Substrates
Muscle Contraction
Cardiomyopathies
Health Care Costs
Phosphorus
Hospitalization
Animal Models
Morbidity
Health care
Metabolism
Risk assessment
Survival

Keywords

  • Creatine kinase
  • Dilated cardiomyopathy
  • Energymetabolism
  • Heart
  • Heart failure
  • Hypertrophic cardiomyopathy heart failure
  • Magnetic resonance spectroscopy (MRS)
  • Myocardial energy
  • Phosphorus (31P)

ASJC Scopus subject areas

  • Analytical Chemistry
  • Spectroscopy
  • Biomedical Engineering
  • Biochemistry
  • Radiology Nuclear Medicine and imaging

Cite this

MRS in the failing heart : From mice to humans. / Weiss, Robert George; Gupta, Ashish; Bottomley, Paul A.

In: eMagRes, Vol. 5, No. 2, 2016, p. 1271-1282.

Research output: Contribution to journalArticle

Weiss, Robert George ; Gupta, Ashish ; Bottomley, Paul A. / MRS in the failing heart : From mice to humans. In: eMagRes. 2016 ; Vol. 5, No. 2. pp. 1271-1282.
@article{bbf881d0d1914a62972259505431456c,
title = "MRS in the failing heart: From mice to humans",
abstract = "Heart failure (HF) affects over 5 million Americans and takes a significant toll of morbidity, mortality, and health-care costs worldwide. The hypothesis that abnormalities in myocardial energy production are present and underlie human HF is logical and compelling. Adenosine triphosphate (ATP) is the biochemical energy that fuels muscular contraction, and creatine kinase (CK) reaction is the primary energy reserve. Phosphorus (31P) magnetic resonance spectroscopy (MRS) is uniquely capable of measuring the principle substrates in the CK reaction in the living heart noninvasively. Experimental studies in animal models show that reductions in myocardial CK energy reserve significantly limit contractile reserve in normal hearts. Moreover, substrate reductions of [ATP], phosphocreatine (PCR), and PCR/ATP ratios observed by 31P MRS in failing hearts coincide with impaired systolic and diastolic function. The consistency of these findings across multiple species and etiologies argues strongly that metabolic abnormalities in CK energy reserve are a critical component of HF, possibly contributing to its pathophysiology. The recent extension of 31P MRS to noninvasive measurements of ATP flux through CK shows flux reductions in mild-to-moderate human HF that exceed those in the underlying substrates, and reduced CK flux is an independent predictor of subsequent clinical HF events including hospitalizations and death. Mouse models in which expression of CK is knocked out, augmented, or switched on and off are available. In two different murine models of cardiomyopathy, these methods showed that CK overexpression improves contractile function and survival. These findings suggest that impaired cardiac energetics play a central role in HF, that 31P MRS measurements could complement existing risk assessment metrics for HF patients, that strategies to augment CK ATP metabolism in the failing human heart should be pursued and that 31P MRS offers a powerful and unique tool to evaluate both the underlying causes of HF and new treatment strategies.",
keywords = "Creatine kinase, Dilated cardiomyopathy, Energymetabolism, Heart, Heart failure, Hypertrophic cardiomyopathy heart failure, Magnetic resonance spectroscopy (MRS), Myocardial energy, Phosphorus (31P)",
author = "Weiss, {Robert George} and Ashish Gupta and Bottomley, {Paul A}",
year = "2016",
doi = "10.1002/9780470034590.emrstm1466",
language = "English (US)",
volume = "5",
pages = "1271--1282",
journal = "eMagRes",
issn = "2055-6101",
publisher = "Blackwell",
number = "2",

}

TY - JOUR

T1 - MRS in the failing heart

T2 - From mice to humans

AU - Weiss, Robert George

AU - Gupta, Ashish

AU - Bottomley, Paul A

PY - 2016

Y1 - 2016

N2 - Heart failure (HF) affects over 5 million Americans and takes a significant toll of morbidity, mortality, and health-care costs worldwide. The hypothesis that abnormalities in myocardial energy production are present and underlie human HF is logical and compelling. Adenosine triphosphate (ATP) is the biochemical energy that fuels muscular contraction, and creatine kinase (CK) reaction is the primary energy reserve. Phosphorus (31P) magnetic resonance spectroscopy (MRS) is uniquely capable of measuring the principle substrates in the CK reaction in the living heart noninvasively. Experimental studies in animal models show that reductions in myocardial CK energy reserve significantly limit contractile reserve in normal hearts. Moreover, substrate reductions of [ATP], phosphocreatine (PCR), and PCR/ATP ratios observed by 31P MRS in failing hearts coincide with impaired systolic and diastolic function. The consistency of these findings across multiple species and etiologies argues strongly that metabolic abnormalities in CK energy reserve are a critical component of HF, possibly contributing to its pathophysiology. The recent extension of 31P MRS to noninvasive measurements of ATP flux through CK shows flux reductions in mild-to-moderate human HF that exceed those in the underlying substrates, and reduced CK flux is an independent predictor of subsequent clinical HF events including hospitalizations and death. Mouse models in which expression of CK is knocked out, augmented, or switched on and off are available. In two different murine models of cardiomyopathy, these methods showed that CK overexpression improves contractile function and survival. These findings suggest that impaired cardiac energetics play a central role in HF, that 31P MRS measurements could complement existing risk assessment metrics for HF patients, that strategies to augment CK ATP metabolism in the failing human heart should be pursued and that 31P MRS offers a powerful and unique tool to evaluate both the underlying causes of HF and new treatment strategies.

AB - Heart failure (HF) affects over 5 million Americans and takes a significant toll of morbidity, mortality, and health-care costs worldwide. The hypothesis that abnormalities in myocardial energy production are present and underlie human HF is logical and compelling. Adenosine triphosphate (ATP) is the biochemical energy that fuels muscular contraction, and creatine kinase (CK) reaction is the primary energy reserve. Phosphorus (31P) magnetic resonance spectroscopy (MRS) is uniquely capable of measuring the principle substrates in the CK reaction in the living heart noninvasively. Experimental studies in animal models show that reductions in myocardial CK energy reserve significantly limit contractile reserve in normal hearts. Moreover, substrate reductions of [ATP], phosphocreatine (PCR), and PCR/ATP ratios observed by 31P MRS in failing hearts coincide with impaired systolic and diastolic function. The consistency of these findings across multiple species and etiologies argues strongly that metabolic abnormalities in CK energy reserve are a critical component of HF, possibly contributing to its pathophysiology. The recent extension of 31P MRS to noninvasive measurements of ATP flux through CK shows flux reductions in mild-to-moderate human HF that exceed those in the underlying substrates, and reduced CK flux is an independent predictor of subsequent clinical HF events including hospitalizations and death. Mouse models in which expression of CK is knocked out, augmented, or switched on and off are available. In two different murine models of cardiomyopathy, these methods showed that CK overexpression improves contractile function and survival. These findings suggest that impaired cardiac energetics play a central role in HF, that 31P MRS measurements could complement existing risk assessment metrics for HF patients, that strategies to augment CK ATP metabolism in the failing human heart should be pursued and that 31P MRS offers a powerful and unique tool to evaluate both the underlying causes of HF and new treatment strategies.

KW - Creatine kinase

KW - Dilated cardiomyopathy

KW - Energymetabolism

KW - Heart

KW - Heart failure

KW - Hypertrophic cardiomyopathy heart failure

KW - Magnetic resonance spectroscopy (MRS)

KW - Myocardial energy

KW - Phosphorus (31P)

UR - http://www.scopus.com/inward/record.url?scp=85021353637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021353637&partnerID=8YFLogxK

U2 - 10.1002/9780470034590.emrstm1466

DO - 10.1002/9780470034590.emrstm1466

M3 - Article

AN - SCOPUS:85021353637

VL - 5

SP - 1271

EP - 1282

JO - eMagRes

JF - eMagRes

SN - 2055-6101

IS - 2

ER -